Magician Dynamo, real name Steven Frayne, appeared on BBC Breakfast to discuss his upcoming residency in London ...
A new machine learning model predicts the need for temporary stoma formation after intestinal resection in Crohn’s disease, ...
Steven Frayne, aka Dynamo, has revealed he "couldn't even shuffle cards" as he opened up on a debilitating health condition.
11h
Hosted on MSNIndiana Child With Crohn’s Disease Receives “Magical Dream” Trip To Florida Theme ParksA 10-year-old Indiana boy with Crohn's disease recently experienced a dream come true thanks to the Sunshine Foundation.
"American Pickers" star Frank Fritz's family is contesting his estate, and claims the reality star may not have had a valid will at the time of his death.
Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) ...
Biocon share price rose by 2.5% after its arm launched Yesintek, a biosimilar for autoimmune disorders in the US. Approved ...
Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
A British study found that virtual chromoendoscopy has a higher neoplasia detection rate than other endoscopic modalities ...
Biocon Biologics launches Yesintek biosimilar to Stelara in US: Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:40 Hrs [IST] Biocon Biologics has announced that Yesintek (ust ...
By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...
Biocon added 1.36% to Rs 325.25 after the company announced that its subsidiary, Biocon Biologics (BBL), has launched YESINTEK (ustekinumab-kfce) in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results